Inhibition of Paenibacillus larvae by an extracellular protein fraction from a honeybee-borne Brevibacillus laterosporus strain

Microbiol Res. 2019 Oct:227:126303. doi: 10.1016/j.micres.2019.126303. Epub 2019 Jul 19.

Abstract

The inhibitory action that a Brevibacillus laterosporus strain isolated from the honeybee body causes against the American Foulbrood (AFB) etiological agent Paenibacillus larvae was studied by in-vitro experiments. A protein fraction isolated from B. laterosporus culture supernatant was involved in the observed inhibition of P. larvae vegetative growth and spore germination. As a result of LC-MS/MS proteomic analyses, the bacteriocin laterosporulin was found to be the major component of this fraction, followed by other antimicrobial proteins and substances including lectins, chaperonins, various enzymes and a number of putative uncharacterized proteins. The results obtained in this study highlight the potential of B. laterosporus as a biological control agent for preserving and improving honeybee health.

Keywords: American foulbrood; Antimicrobial; Apis mellifera; Bacteria; Laterosporulin.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Bacterial Proteins / isolation & purification*
  • Bacterial Proteins / metabolism
  • Bacterial Proteins / pharmacology*
  • Bacteriocins / isolation & purification
  • Bacteriocins / pharmacology
  • Bees / microbiology*
  • Brevibacillus / isolation & purification
  • Brevibacillus / metabolism*
  • Chromatography, Liquid
  • Microbial Sensitivity Tests
  • Paenibacillus larvae / drug effects*
  • Proteomics
  • Tandem Mass Spectrometry

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Bacteriocins
  • laterosporulin